Type 2 Diabetes Mellitus Treatment Market Analysis by top key players

Posted by Market Research Future on March 24th, 2020

The Global Type 2 Diabetes Mellitus Market is expected to exhibit an upswing and capture a CAGR of 8% over the forecast period of 2017-2023, proclaims Market Research Future (MRFR) in an exhaustive research report. The global market is expanding at a rapid pace due to the increasing burden of type 2 diabetes across the globe. Type 2 diabetes mellitus has been increasing exponentially, and the market has observed a high prevalence rate in both developed and developing countries due to multiple risk factors of diabetes and delayed diagnosis. Development of novel efficient therapies is expected to create a supportive dais for building up the global type 2 diabetes mellitus market. The inefficiency of current therapies and life-threatening complications arising out of type 2 diabetes mellitus has necessitated the development of appropriate preventive measures. 

 The government of various countries have initiated awareness programs and are investing heavily in research & development. Moreover, there has been a rise in the number of FDA approvals for new drugs which have also helped the market expand. Other driving factors include an increase in healthcare expenditure on a global scale and a rise in risk factors of type 2 diabetes mellitus. Conversely, the market growth might be hindered by lack of awareness, the high cost of treatment and diagnosis, complex regulatory framework for FDA approvals of therapies, and the side effects of available treatment options. 

Segmentation

The global type 2 diabetes mellitus treatment market has been segmented based on treatment and end user. By treatment, the market has been segmented into drug and devices. The drug segment has been further segmented into Insulin, Sensitizers, Sglt-2, Alpha-Glycosidase Inhibitors, Others. The devices segment has been further segmented into Blood Glucose Monitoring, Insulin Delivery Devices. By end user, the market has been segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others. 

Regional Analysis

The global type 2 diabetes mellitus treatment market spans across the regions of the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas account for the largest share of the global type 2 diabetes mellitus market owing to the presence of a huge patient pool, well-developed healthcare sector, and the presence of leading players in the region. Moreover, due to the rising burden of diabetes mellitus on the healthcare, various companies and governments are endeavoring towards improving diabetes care. Europe is the second largest market for type 2 diabetes mellitus market. Government grants for research & Development coupled with favorable reimbursement scenario drive the market in Europe. Throughout Europe, charges for diagnosis and treatment of type 2 diabetes mellitus are covered under health insurance, especially for pregnant women. Asia Pacific is poised to be the fastest growing market on account of an epidemic increase in diabetes occurrence in the region which induces high demand for treatment and diagnosis. Also, the market is expanding due to substantial investment in the healthcare sector by the governments in the region. The Middle East & Africa market accounts for the least share of the market due to low healthcare penetration and poor medical facilities, especially in the Africa region. The Middle East market is expected to exhibit considerable growth over the forecast period due to improving the healthcare sector in the region. 

Competitive Landscape

The notable players operating in the global type 2 diabetes mellitus treatment market include Abbott Laboratories, Adocia, Amgen, Bayer AG, Dickinson and Company,  Boehringer Ingelheim, Eli Lilly,  Novo Nordisk, Pfizer, Sanofi,  Takeda Pharmaceuticals, Acon Laboratories, Inc., Akros Pharma, AstraZeneca, Becton, Biocon, Daiichi Sankyo, Merck, Novartis & Co., Peptron, Roche Diagnostics Ltd., Sunpharma, and others. 

Read More @ https://www.marketresearchfuture.com/reports/type-2-diabetes-mellitus-treatment-market-5669